Nonischemic cardiomyopathy

I9_NONISCHCARDMYOP_STRICT

dilated cardiomyopathy: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions not I9_IHD and not I9_HYPERTROCARDMYOP	428131
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42.0, I50.1 Hospital discharge: ICD-9 — 4281 Cause of death: ICD-10 — I42.0, I50.1 Cause of death: ICD-9 — 4281 2 out of 7 registries used, show all original rules.	4215
4. Check minimum number of events None	4215
5. Include endpoints None	4215
6. Filter based on genotype QC (FinnGen only)	4112

Control definitions (FinnGen only)

Control conditions: not I9_IHD
and not I9_HYPERTROCARDMYOP

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	I9_NONISCHCARDMYOP_STRICT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!I9_IHD&!I9_HYPERTROCARDMYOP
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!I9_IHD&!I9_HYPERTROCARDMYOP
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I420\|I501
HD_ICD_9	4281
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I420\|I501
COD_ICD_9	4281
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Nonischemic cardiomyopathy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4112	1452	2660
Unadjusted period prevalence (%)	0.97	0.52	1.22
Median age at first event (years)	65.40	66.65	64.72

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4215: Matched controls
42107

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.3

309.3

2572

13500

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

24.4

307.7

384

172

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

13.2

307.7

1035

1013

C09AA05

ATC

ramipril; oral

7.4

307.7

2301

5858

I50.1

ICD-10 Finland

Left ventricular failure

4898.0

307.7

2853

B01AA03

ATC

warfarin; systemic

5.7

307.7

1775

4749

C03DA01

ATC

spironolactone; oral

19.2

307.7

2133

2132

I50

ICD-10 Finland

Heart failure

11.8

307.7

412

384

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

40.1

307.7

340

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

4.8

307.7

1315

3608

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

1488.4

307.7

404

C09DX04

ATC

valsartan and sacubitril; oral

1231.4

307.7

442

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

12.3

307.7

613

576

XF404

NOMESCO Finland

Ambulatory ECG

5.6

307.7

766

1596

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

14.2

307.7

815

700

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

134.8

307.7

661

TFP20

NOMESCO Finland

Cardiodefibrillation

6.5

307.7

811

1481

I50.0

ICD-10 Finland

Congestive heart failure

17.3

307.7

1181

929

I42.0

ICD-10 Finland

Dilated cardiomyopathy

5726.9

307.7

2193

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.3

307.7

2182

4842

207

Kela drug reimbursment

Chronic arrhythmias

6.9

307.7

1655

3585

201

Kela drug reimbursment

Chronic cardiac insufficiency

85.9

307.7

1850

380

A10BK01

ATC

dapagliflozin; oral

7.0

307.7

774

1304

I50.9

ICD-10 Finland

Heart failure, unspecified

22.7

307.7

2439

2398

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.4

307.7

1811

3454

C03CA01

ATC

furosemide; systemic

13.1

307.7

3145

7711

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.0

307.7

1471

4071

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

135.7

307.7

182

C01BD01

ATC

amiodarone; systemic

20.7

307.7

504

274

AN1

Coronary angiography

18.0

307.7

704

463

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

1824.8

307.7

473

I48

ICD-10 Finland

Atrial fibrillation and flutter

6.0

307.7

2066

5794

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

19.8

307.7

258

138

C01AA05

ATC

digoxin; systemic

10.5

307.7

1162

1475

I47.2

ICD-10 Finland

Ventricular tachycardia

18.7

307.7

285

163

250, ,

Kela drug reimbursment

106.4

307.7

515

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

20.3

307.7

1889

1617

K77

ICPC

Heart failure

15.9

307.7

320

217

I48.2

ICD-10 Finland

Chronic atrial fibrillation

8.7

307.7

555

723

C07AB07

ATC

bisoprolol; oral

10.7

307.7

3478

12884

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

5.1

307.0

732

1661

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.4

303.0

550

972

GD1LA

NOMESCO Finland

16.7

291.8

248

157

I42.8

ICD-10 Finland

Other cardiomyopathies

102.8

288.3

149

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.8

278.9

1068

3451

B01AF02

ATC

apixaban; oral

3.9

271.2

981

3044

R06.0

ICD-10 Finland

Dyspnoea

3.2

268.2

1495

6103

I48.1

ICD-10 Finland

Persistent atrial fibrillation

6.8

259.9

431

692

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

7.1

253.6

403

618

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

75.0

243.4

131

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

4.5

228.2

626

1574

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

118.1

225.6

115

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

41.5

220.3

133

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

14.3

209.6

193

141

K78

ICPC

Atrial fibrillation/flutter

4.2

208.7

631

1703

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

11.0

200.1

217

206

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

11.8

194.1

201

178

Angiography of the heart and coronary arteries

13.1

191.2

185

147

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

9.0

190.2

240

280

A10BK03

ATC

empagliflozin; oral

3.8

187.2

652

1938

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

179.2

940

3600

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

174.1

166

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

225.2

168.4

173

K84

ICPC

Heart disease other

8.5

162.8

215

265

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

6.0

155.9

287

507

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

4.5

153.4

396

940

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

31.6

152.2

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.6

150.5

553

1692

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

28.7

150.5

101

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

8.2

148.1

200

253

M04AA01

ATC

allopurinol; systemic

2.9

147.3

845

3368

AP1

Catheterization of the left side of the heart

21.3

135.8

102

WX892

NOMESCO Finland

Monitored bed care

3.7

132.9

468

1388

I44.2

ICD-10 Finland

Atrioventricular block, complete

6.1

130.8

233

398

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

11.0

130.0

140

131

TFP34

NOMESCO Finland

Electrophysiological investigation

5.6

126.4

246

457

WX872

NOMESCO Finland

Intensive care

4.8

124.5

291

635

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

22.1

123.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.6

117.1

415

1233

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

12.5

116.5

115

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

8.5

111.4

145

175

XF640, ,

NOMESCO Finland

5.7

109.3

210

385

XFE00

NOMESCO Finland

Epicardial ultrasonography

7.4

105.9

156

218

R02

ICPC

Shortness of breath/dyspnoea

2.7

103.7

634

2578

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

39.3

101.2

1CX08, ,

NOMESCO Finland

120.7

98.4

106

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

96.6

1318

7556

I34.1

ICD-10 Finland

Mitral (valve) prolapse

5.0

95.3

211

439

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

8.3

93.0

124

154

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.1

92.4

418

1439

XF402

NOMESCO Finland

ECG with work load test

3.0

91.2

453

1644

C07AA07

ATC

sotalol; systemic

4.3

90.3

245

600

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

89.6

563

2311

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

5.8

89.4

167

298

ZXD05

NOMESCO Finland

Urgent procedure

2.0

89.1

1236

7092

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.0

88.4

264

694

I49.3

ICD-10 Finland

Ventricular premature depolarization

3.1

86.4

387

1323

XF409

NOMESCO Finland

Other special ECG

15.4

83.6

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

83.6

1003

5436

M10.9

ICD-10 Finland

Gout, unspecified

2.9

83.5

428

1578

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.7

82.7

271

760

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

813.1

81.7

ZX120

NOMESCO Finland

Intravenous

2.7

80.1

486

1955

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

47.5

80.1

H02AB06

ATC

prednisolone; systemic

1.8

76.7

2020

14134

A12BA01

ATC

potassium chloride; oral

3.8

76.0

242

665

I42

ICD-10 Finland

Cardiomyopathy

373.5

73.9

TFJ02

NOMESCO Finland

Muscle biopsy of heart

114.9

73.1

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

16.7

72.8

C07AB02

ATC

metoprolol; systemic

2.1

71.2

787

4107

FL1AC

NOMESCO Finland

Left cardioangiography

11.6

69.7

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

6.3

69.7

118

191

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

347.5

68.7

C07AG02

ATC

carvedilol; oral

3.0

67.5

318

1115

ZXE00

NOMESCO Finland

One hour or less

1.8

67.2

1567

10454

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

64.4

494

2211

I49.5

ICD-10 Finland

Sick sinus syndrome

3.6

64.3

216

615

L04AA06

ATC

mycophenolic acid; systemic

5.7

64.2

120

214

127

Kela drug reimbursment

Transplant complication

6.2

64.0

111

184

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

63.6

836

4629

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.4

63.3

238

729

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.8

62.6

195

527

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.8

62.3

194

524

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

62.3

611

3031

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

62.2

1057

6375

AP4

Myocardial biopsy

133.9

62.0

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

10.8

61.9

TK800

NOMESCO Finland

Hemodialysis

4.9

61.3

136

283

A46

ICD-10 Finland

Erysipelas

2.0

60.2

723

3870

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.7

60.1

356

1408

B01AB05

ATC

enoxaparin; parenteral

1.8

59.9

1354

8883

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

59.9

521

2458

C01DA14

ATC

isosorbide mononitrate; oral

3.1

59.7

265

897

Z94.1

ICD-10 Finland

Heart transplant status

75.7

59.2

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.2

57.8

582

2912

K99

ICPC

Cardiovascular disease other

3.9

57.5

173

456

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

8.1

56.7

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

554.8

55.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

55.6

304

1153

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.8

54.5

280

1028

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

54.0

335

1354

TFP35

NOMESCO Finland

Electroanatomical mapping

5.5

53.8

105

195

L04AD02

ATC

tacrolimus; systemic

7.2

52.4

110

R4110

NOMESCO Finland

Physiotherapy

1.8

52.2

1138

7335

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

113.4

51.9

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

51.7

453

2138

B01AF01

ATC

rivaroxaban; oral

2.0

50.2

621

3343

C09AA02

ATC

enalapril; systemic

1.8

50.0

871

5246

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

49.0

K83

ICPC

Heart valve disease NOS

6.5

48.9

125

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

48.9

684

3838

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.6

48.5

115

253

R03BB04

ATC

tiotropium bromide; inhalant

2.1

47.9

476

2359

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

18.2

47.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

46.3

1103

7247

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

5.0

46.2

200

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

46.1

173

529

E05.89

ICD-10 Finland

Other thyrotoxicosis

17.7

45.4

AP2

Catheterization of the right side of the heart

17.7

45.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

45.1

1134

7552

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

11.3

44.8

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

6.0

44.4

131

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

10.8

44.4

Z2221

NOMESCO Finland

Medical doctor

1.7

44.0

1034

6756

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.1

43.6

122

305

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.1

43.1

186

619

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

10.5

42.8

Initial pacemaker installation

10.5

42.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

42.4

527

2830

Z3231

NOMESCO Finland

Registered nurse

1.7

42.4

1096

7331

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

216.9

41.9

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.0

41.9

119

301

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

10.6

41.0

AA1AD

NOMESCO Finland

CT of head and brain

1.6

41.0

1140

7756

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

12.2

41.0

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

40.7

218

817

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

6.2

40.6

112

WX722

NOMESCO Finland

PEEP

2.7

40.0

223

853

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.1

39.8

173

578

A10BA02

ATC

metformin; oral

1.6

39.6

1134

7759

M10.0

ICD-10 Finland

Idiopathic gout

2.9

39.3

186

652

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

74.2

38.9

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

38.8

132

379

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

38.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

38.2

696

4215

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

9.5

37.9

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.8

37.2

189

689

C09AA04

ATC

perindopril; oral

2.5

37.0

237

970

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.4

37.0

132

391

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

54.2

36.4

E87.5

ICD-10 Finland

Hyperkalaemia

4.1

36.2

101

252

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

36.0

181

656

N19

ICD-10 Finland

Unspecified kidney failure

2.9

35.9

178

640

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

35.8

267

1172

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

35.3

332

1604

C09CA03

ATC

valsartan; oral

2.0

35.2

408

2132

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

9.6

35.0

B01AF03

ATC

edoxaban; oral

3.5

35.0

122

356

E66.8

ICD-10 Finland

Other obesity

2.7

34.5

190

722

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.5

34.2

227

945

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

34.0

183

687

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

34.0

468

2592

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

34.0

226

942

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

6.8

33.9

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

4.1

33.1

225

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

32.9

674

4203

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

329.4

32.9

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

32.7

305

1468

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.9

32.6

155

545

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

32.5

950

6484

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

32.4

211

871

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

5.5

32.2

114

I48.3

ICD-10 Finland

Typical atrial flutter

5.0

32.1

140

A10BH05

ATC

linagliptin; oral

2.4

32.0

222

943

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

31.8

1425

10679

FN1AD

NOMESCO Finland

CT of coronary arteries

4.9

31.8

145

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

31.6

398

2139

WX740

NOMESCO Finland

Nitrogen oxide therapy

47.8

31.5

AS4

Physiological pacemaker insertion DDD (R)

4.6

31.4

166

R03AC02

ATC

salbutamol; inhalant

1.5

31.4

1909

15192

Catheterization and pressure measurement of the left side of the heart

9.3

30.9

M10

ICD-10 Finland

Gout

2.4

30.8

222

959

B01AE07

ATC

dabigatran etexilate; oral

2.6

30.8

190

764

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

4.5

30.8

173

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

30.5

352

1834

TK810

NOMESCO Finland

Hemofiltration

6.9

30.5

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

11.1

30.2

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

7.7

30.1

C01BC04

ATC

flecainide; systemic

2.6

30.1

172

666

A11CC03

ATC

alfacalcidol; systemic

3.4

30.1

111

336

S97

ICPC

Chronic ulcer skin

2.2

30.0

270

1282

C08DA01

ATC

verapamil; systemic

2.6

29.9

178

703

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

304.3

29.8

T90

ICPC

Diabetes non-insulin dependent

1.6

29.8

931

6437

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

28.8

29.8

J96.1

ICD-10 Finland

Chronic respiratory failure

3.3

29.5

112

345

3AC01, ,

NOMESCO Finland

5.6

29.2

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

29.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

29.1

154

573

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

293.7

28.8

AS7

Arrhythmia pacemaker insertion VVI (R) S

104.0

28.7

I44.1

ICD-10 Finland

Atrioventricular block, second degree

3.4

28.6

103

307

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

28.5

2853

31820

A02BC02

ATC

pantoprazole; systemic

1.4

28.5

2542

21574

3A064, ,

NOMESCO Finland

9.8

28.5

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

28.2

216

959

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.3

28.0

106

326

SPAT1263

SPAT

Sampling

1.5

27.9

1490

11491

R04.0

ICD-10 Finland

Epistaxis

2.0

27.8

318

1650

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.9

27.8

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

3.0

27.4

119

398

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

10.1

27.3

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

53.7

27.2

J81

ICD-10 Finland

Pulmonary oedema

10.4

27.1

J01MA12

ATC

levofloxacin; systemic

1.6

26.9

750

5037

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

26.9

1225

9144

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

26.7

221

1013

AS2

Ventricular pacemaker insertion VVI (R)

6.7

26.7

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

26.6

207

925

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.3

26.6

215

977

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

26.5

249

1201

AC4

MVP

7.4

26.2

H03BB01

ATC

carbimazole; oral

2.6

26.2

150

582

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.4

26.1

149

J01MA14

ATC

moxifloxacin; systemic

1.9

26.1

353

1940

A10AE04

ATC

insulin glargine; parenteral

1.9

25.9

352

1937

XG466

NOMESCO Finland

Sleep oxymetry

2.7

25.8

145

557

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

25.7

1337

10219

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

262.0

25.7

JN4AD

NOMESCO Finland

Body CT examination

1.8

25.6

443

2625

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.4

25.4

148

J96.0

ICD-10 Finland

Acute respiratory failure

4.2

25.4

165

M01AH05

ATC

etoricoxib; oral

0.7

25.4

1574

19308

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

5.1

25.4

105

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

25.2

166

689

I51.4

ICD-10 Finland

Myocarditis, unspecified

8.0

25.1

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.8

25.0

118

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

24.9

186

816

Electrophysiological Special Examination

6.7

24.6

R55

ICD-10 Finland

Syncope and collapse

1.8

24.5

423

2503

AP3

Catheterization of the right and left side of the heart

27.7

24.4

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

24.4

221

1051

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

24.2

233

1134

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

24.2

171

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.1

24.0

159

T92

ICPC

Gout

3.0

23.8

108

370

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

23.8

199

916

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

23.8

434

2608

205

Kela drug reimbursment

Chronic hypertension

1.5

23.6

1082

8049

I48.4

ICD-10 Finland

Atypical atrial flutter

6.3

23.5

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

5.9

23.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

23.5

700

4762

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

23.3

213

1016

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

23.3

702

4784

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.2

23.3

301

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

46.9

23.3

FM1EE, ,

SPAT

4.3

23.2

142

FXE00

NOMESCO Finland

Use of ECLA

+∞

22.9

J01FF01

ATC

clindamycin; systemic

1.5

22.6

963

7054

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

22.5

288

1552

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

22.4

509

3241

AQ1

Conventional electrophysiological examination

4.4

22.4

125

C07AB03

ATC

atenolol; systemic

2.1

22.2

222

1096

N02BE01

ATC

paracetamol; systemic, rectal

1.5

22.2

3448

31561

E86

ICD-10 Finland

Volume depletion

2.8

22.1

110

397

A12AA04

ATC

calcium carbonate; oral

3.8

21.8

180

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

21.7

330

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

7.7

21.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

21.6

997

7409

R4190

NOMESCO Finland

Nutritional therapy

2.4

21.5

149

633

Catheter ablation of arrhythmia

6.1

21.5

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

21.5

488

3106

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

21.4

260

1377

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

21.3

1475

11761

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.3

21.0

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

16.6

20.9

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

20.8

388

2344

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

20.7

415

2555

J01DB01

ATC

cefalexin; oral

1.4

20.6

3129

28239

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

20.5

321

1844

C10AA05

ATC

atorvastatin; oral

1.4

20.5

1415

11265

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.7

20.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

20.2

127

516

A10AC01

ATC

insulin (human); parenteral

1.9

20.2

248

1318

212

Kela drug reimbursment

Gout

2.8

20.2

103

377

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.4

20.1

137

578

C03AA03

ATC

hydrochlorothiazide; oral

1.8

20.0

337

1977

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

19.9

512

3357

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

19.8

1317

10406

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.0

19.7

305

G47.3

ICD-10 Finland

Sleep apnoea

1.5

19.7

833

6074

I95.9

ICD-10 Finland

Hypotension, unspecified

3.6

19.6

184

N17.8

ICD-10 Finland

Other acute renal failure

3.7

19.6

170

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

19.6

2374

20567

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.8

19.5

100

367

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

19.5

154

693

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

19.5

183

883

Z3226

NOMESCO Finland

Physiotherapist

1.5

19.4

628

4336

A10BJ06

ATC

semaglutide; parenteral

2.2

19.4

173

819

Q23.11

ICD-10 Finland

Bicuspid aortic valve

4.2

19.2

119

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

19.2

422

2662

Z71.8

ICD-10 Finland

Other specified counselling

1.4

19.1

986

7449

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.4

19.1

111

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

19.1

222

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

5.7

18.9

WX882

NOMESCO Finland

High dependency care

2.6

18.9

112

443

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

34.4

18.9

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

70.1

18.7

Z2446

NOMESCO Finland

Social worker

1.9

18.7

226

1196

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.7

18.6

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

14.2

18.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

18.5

763

5530

R50.9

ICD-10 Finland

Fever, unspecified

1.6

18.4

529

3557

H02AB07

ATC

prednisone; oral

1.6

18.3

487

3214

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.5

18.2

174

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

44.1

18.2

WX902

NOMESCO Finland

External defibrillation of heart

6.9

18.2

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

18.2

100

381

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.2

18.1

229

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

17.9

251

1393

N18.0

ICD-10 Finland

End-stage renal disease

4.0

17.8

122

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

17.7

1017

7811

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.8

17.7

ZX108

NOMESCO Finland

Inhalation

4.7

17.7

N02AX02

ATC

tramadol; systemic, rectal

1.3

17.7

1565

12870

WZC30

NOMESCO Finland

Teaching

1.5

17.6

567

3905

132

Kela drug reimbursment

Sarcoidosis

4.6

17.5

WX730

NOMESCO Finland

Conventional respirator

3.3

17.3

205

J94.8

ICD-10 Finland

Other specified pleural conditions

3.1

17.3

241

L04AX01

ATC

azathioprine; systemic

2.2

17.3

145

670

7AX01, ,

NOMESCO Finland

50.2

17.0

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

5.9

16.9

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

16.9

218

1178

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

16.9

914

6945

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.5

16.7

107

439

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

16.7

1163

9204

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

6.3

16.7

SPAT1254

SPAT

Administration of medicine

1.5

16.6

514

3507

A41.8

ICD-10 Finland

Other specified sepsis

2.8

16.5

291

I45.3

ICD-10 Finland

Trifascicular block

5.3

16.5

XF622

NOMESCO Finland

Measurement of minute volume of heart

7.3

16.5

Catheterization and pressure measurement of the right side of the heart

13.4

16.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

16.4

199

1055

L28

ICPC

Limited function/disability (L)

1.5

16.3

656

4718

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

16.3

407

2644

3025

Kela drug reimbursment

Calcium carbonate

5.7

16.3

K28

ICPC

Limited function/disability (K)

2.7

16.3

333

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

16.2

1390

11339

S18

ICPC

Laceration/cut

1.3

16.2

1696

14236

A10BH01

ATC

sitagliptin; oral

1.7

16.2

341

2125

WW500

NOMESCO Finland

Blood transfusion

2.1

16.2

155

755

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

5.5

16.1

I51.7

ICD-10 Finland

Cardiomegaly

6.0

16.0

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

24.5

16.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

16.0

208

1128

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

15.9

174

889

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.9

238

1348

B01AB04

ATC

dalteparin; parenteral

1.9

15.8

195

1038

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

15.8

212

1161

SPAT1097

SPAT

Recording of ECG

1.5

15.7

498

3412

WX930

NOMESCO Finland

Thepapeutic hypothermia

33.4

15.7

R04.2

ICD-10 Finland

Haemoptysis

2.1

15.7

141

670

Cardiac muscle biopsy

+∞

15.6

SPAT1252

SPAT

Overall medication plan or its review

1.8

15.6

249

1438

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

15.6

107

454

160

Kela drug reimbursment

exenatide

2.8

15.6

267

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

85.3

15.6

SPAT1255

SPAT

Intravenous administration of medicine

1.8

15.6

253

1469

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

15.5

109

467

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

15.5

183

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

15.5

228

1284

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

22.1

15.5

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

15.5

573

4054

A08

ICPC

Swelling

1.9

15.4

191

1019

TGC00

NOMESCO Finland

Bronchial lavation

2.4

15.4

103

432

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.3

15.2

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

15.1

170

878

FA1AC

NOMESCO Finland

Upper cavography

45.1

15.0

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.6

15.0

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

4.8

14.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

14.9

268

K29

ICPC

Cardiovascular sympt/complt other

2.0

14.9

159

806

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

5.8

14.9

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.3

14.9

112

495

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

4.1

14.9

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

11.3

14.7

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

14.7

113

504

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

4.9

14.7

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

25.1

14.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

14.6

538

3800

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

14.6

412

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

80.3

14.6

Z94.0

ICD-10 Finland

Kidney transplant status

3.7

14.6

122

742, ,

NOMESCO Finland

11.9

14.5

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

14.5

206

1148

C09CA01

ATC

losartan; oral

1.4

14.5

930

7239

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.5

14.5

146

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

150.4

14.5

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

14.4

546

3877

C09AA01

ATC

captopril; oral

3.0

14.4

218

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.7

14.3

291

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

14.2

155

792

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.4

14.2

153

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

14.1

210

1187

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

14.1

776

5889

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

14.1

265

1603

SPAT1260

SPAT

Consultation of another employee

1.4

14.1

589

4262

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.3

14.0

164

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

2.9

13.9

223

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

12.7

13.9

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

13.8

160

835

R2110

NOMESCO Finland

Giving the first information

1.9

13.8

174

934

WX890

NOMESCO Finland

Intesive care monitoring

5.6

13.8

I44.0

ICD-10 Finland

Atrioventricular block, first degree

2.9

13.8

229

A10AB05

ATC

insulin aspart; parenteral

1.7

13.8

235

1384

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

3.7

13.7

118

AB2

AVR bio, stent

6.5

13.6

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.0

13.6

ASA

Insertion of a biventricular pacemaker VVI (R) S

75.3

13.6

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

13.6

388

2599

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

13.5

196

1100

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

140.3

13.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

13.4

131

643

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

13.4

210

1206

K08.3

ICD-10 Finland

Retained dental root

1.6

13.4

281

1749

J01CA04

ATC

amoxicillin; systemic

1.3

13.3

2913

26631

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

6.3

13.3

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

6.3

13.3

PD5AD

NOMESCO Finland

CT of aorta

2.7

13.2

268

A10BJ02

ATC

liraglutide; parenteral

2.4

13.2

387

Q21.10

ICD-10 Finland

Persistent ostium secundum

9.7

13.2

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

5.7

13.2

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.5

13.1

131

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

13.1

878

6868

K80

ICPC

Cardiac arrhythmia NOS

1.7

13.1

265

1635

5253

FHL

Cardiac lung machine

15.0

13.1

N05CF01

ATC

zopiclone; oral

1.3

13.0

1130

9177

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.6

12.9

118

R60.0

ICD-10 Finland

Localized oedema

1.5

12.9

431

2982

XFP02, ,

NOMESCO Finland

19.1

12.9

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

11.5

12.8

C02EA02, ,

ATC

1.9

12.8

158

844

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

5.3

12.7

V03AE01

ATC

polystyrene sulfonate; oral

2.9

12.7

196

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

4.0

12.6

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

5.5

12.6

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.8

12.5

219

C08DB01

ATC

diltiazem; oral

1.9

12.5

159

856

SPAT1262

SPAT

Handing over of treatment supplies

1.4

12.5

612

4549

C10AA01

ATC

simvastatin; oral

1.3

12.5

1438

12107

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

12.5

401

2753

FM1CD

NOMESCO Finland

Very extensive CT of heart

9.3

12.4

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.0

12.4

182

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

20.1

12.4

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.2

12.4

146

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

12.4

453

3191

L04AD01

ATC

ciclosporin; systemic

2.7

12.4

243

A10BB12

ATC

glimepiride; oral

1.7

12.4

230

1387

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

12.3

137

707

342

Kela drug reimbursment

Dronedarone

3.9

12.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

12.1

130

661

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

12.1

1720

14841

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

12.1

442

C01BA01

ATC

quinidine; oral

4.2

12.0

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

11.9

182

1038

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

11.9

187

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

11.9

1501

12764

C01BB02

ATC

mexiletine; systemic

14.7

11.8

SPAT1285

SPAT

Provision of consultation response

1.8

11.7

172

971

I44.6

ICD-10 Finland

Other and unspecified fascicular block

16.4

11.6

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.5

11.6

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

30.1

11.6

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

11.6

617

4647

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

22.9

11.5

R18

ICD-10 Finland

Ascites

2.4

11.5

336

J20

ICD-10 Finland

Acute bronchitis

1.6

11.5

308

2032

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

11.5

283

Kela drug reimbursment

Ivabradine

+∞

11.5

A28

ICPC

Limited function/disability NOS

1.4

11.4

639

4850

C01EB17

ATC

ivabradine; oral

120.2

11.4

SPAT1325

SPAT

Vaccination

1.3

11.2

1150

9511

I95.2

ICD-10 Finland

Hypotension due to drugs

4.2

11.2

Initial installation of the atrial pacemaker

12.7

11.1

L04AA01

ATC

[U] ciclosporin

3.0

11.1

167

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.4

11.1

330

AB1

AVR mechanical

8.0

11.0

J01FA06

ATC

roxithromycin; oral

1.3

11.0

1288

10824

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

11.0

143

777

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

11.0

461

3331

H02AB04

ATC

methylprednisolone; systemic

1.4

11.0

454

3273

OAB43, ,

SPAT

0.7

10.8

343

4884

G04BE03

ATC

sildenafil; oral

2.3

10.8

340

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.7

1017

8322

RS221, ,

NOMESCO Finland

2.9

10.7

176

K07

ICPC

Swollen ankles/oedema

1.8

10.6

158

895

SPAT1229

SPAT

Assessment of need for aid

1.6

10.6

269

1754

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

10.6

140

766

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

11.2

10.5

R03BA02

ATC

budesonide; inhalant

1.4

10.5

527

3927

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

10.0

10.5

FPJ11

NOMESCO Finland

Revision of biventricular CRT-P (VVIR) generator

+∞

10.4

AK1

HTX (heart transplant)

+∞

10.4

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

10.4

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

32.6

10.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

10.3

276

1822

AH3

Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery

18.8

10.2

5AB14, ,

NOMESCO Finland

11.3

10.0

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

4.3

10.0

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.0

10.0

SPAT1104

SPAT

Monitoring of emergency patient

1.6

10.0

206

1278

R03BB01

ATC

ipratropium bromide; inhalant

1.8

10.0

143

802

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

9.9

302

2049

WW200

NOMESCO Finland

Immunization

2.1

9.9

418

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.8

9.9

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

9.9

426

3091

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

9.9

406

ZX197, ,

NOMESCO Finland

16.7

9.9

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

5.1

9.8

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

9.8

544

4120

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.8

9.7

Z50.0

ICD-10 Finland

Cardiac rehabilitation

9.5

9.7

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

3.3

9.7

111

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

9.7

435

3181

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.6

9.7

221

A10AE05

ATC

insulin detemir; parenteral

1.8

9.6

151

870

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

9.6

111

581

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

9.6

329

2289

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

9.6

230

1482

I45.2

ICD-10 Finland

Bifascicular block

3.9

9.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

9.5

192

1184

WX402

NOMESCO Finland

General anaesthesia

1.3

9.5

654

5115

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

10.0

9.5

I11

ICD-10 Finland

Hypertensive heart disease

3.8

9.5

SPAT1301

SPAT

No procedures

1.3

9.5

1024

8499

RS222, ,

NOMESCO Finland

2.9

9.4

155

R06.2

ICD-10 Finland

Wheezing

1.8

9.4

131

728

J45.8

ICD-10 Finland

Mixed asthma

2.0

9.4

454

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.3

9.4

103

C08CA02

ATC

felodipine; oral

1.5

9.4

324

2256

JN4BD

NOMESCO Finland

Extensive body CT

1.4

9.4

389

2805

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.5

9.2

220

M01AB05

ATC

diclofenac; systemic, rectal

0.8

9.2

1926

21354

J01DA01

ATC

[U] cefalexin

1.2

9.2

2126

19133

WX002

NOMESCO Finland

Sedation and analgesia

1.3

9.2

662

5209

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

9.1

426

5672

FM1AD

NOMESCO Finland

CT of heart

8.3

9.0

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

15.6

9.0

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

36.7

9.0

XF406

NOMESCO Finland

High resolution ECG

36.7

9.0

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

9.0

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.7

9.0

171

R03AC13

ATC

formoterol; inhalant

1.7

9.0

153

904

A10BX07

ATC

[U] liraglutide

2.9

8.9

144

NFQ20

NOMESCO Finland

Amputation of femur

3.4

8.9

E66.0

ICD-10 Finland

Obesity due to excess calories

3.2

8.9

102

137

Kela drug reimbursment

Uraemia requiring dialysis

3.3

8.9

Z49.2

ICD-10 Finland

Other dialysis

3.7

8.9

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

8.9

490

3707

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

8.9

397

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

12.5

8.8

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.4

8.8

250

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.0

8.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.8

1424

12348

WX213

NOMESCO Finland

Lower leg blockade

3.3

8.7

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

8.7

316

2222

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

8.7

447

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.1

8.7

ZXA05

NOMESCO Finland

Left side

1.3

8.7

852

6978

NHQ40

NOMESCO Finland

Amputation of toe

2.5

8.7

221

FM1DE, ,

SPAT

3.9

8.7

C01BA03

ATC

disopyramide; systemic

3.9

8.7

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.6

8.6

180

K60

ICPC

Cardiovascular, Result test/procedure

3.1

8.6

114

EBA00

NOMESCO Finland

Extraction of tooth

1.2

8.6

1144

9704

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.8

8.6

152

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.7

8.6

143

840

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

8.2

8.6

R03AC03

ATC

terbutaline; inhalant

1.4

8.5

394

2893

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

8.5

244

1635

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

8.5

2439

22353

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

20.0

8.5

R03DA04

ATC

theophylline; systemic, rectal

1.6

8.4

190

1206

V03AE02

ATC

sevelamer; oral

4.2

8.4

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

7.3

8.4

FWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of heart and major thoracic vessels

90.2

8.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

8.4

319

2263

SPAT1251

SPAT

Organisation of medication

1.9

8.3

108

588

ZYC03

NOMESCO Finland

Remote contact, text-based

3.5

8.3

R06

ICPC

Nose bleed/epistaxis

2.1

8.3

393

3058, ,

Kela drug reimbursment

+∞

8.3

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

8.3

272

1875

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

8.3

284

1975

XG405

NOMESCO Finland

Education on PEF monitoring

2.5

8.3

208

162

Kela drug reimbursment

liraglutide

2.9

8.2

128

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

8.2

1346

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.8

8.2

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.1

8.2

382

L03AA13

ATC

pegfilgrastim; parenteral

1.7

8.2

134

783

AC2

MVR bio

14.5

8.2

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.6

8.1

116

1979

AS5

Biventricular heart failure pacemaker insertion VVI (R)

33.4

8.1

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3.5

8.1

C01BD07

ATC

dronedarone; oral

3.5

8.1

M10.2

ICD-10 Finland

Drug-induced gout

8.1

Mitral valve Replacement (MVR)

17.2

8.1

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.3

8.0

273

B05DB

ATC

Hypertonic solutions

3.8

8.0

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.3

8.0

248

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

6.3

8.0

V03AE03

ATC

lanthanum carbonate; oral

7.2

7.9

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

7.9

340

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

7.9

498

J01CF05

ATC

flucloxacillin; systemic

1.6

7.9

184

1178

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

13.0

7.9

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

10.8

7.8

FN1BD

NOMESCO Finland

Extensive CT of coronary arteries

10.8

7.8

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

7.7

140

842

OAA80, ,

SPAT

0.5

7.7

1665

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.2

7.7

120, ,

NOMESCO Finland

45.0

7.7

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

15.0

7.7

AD1

TVP

15.0

7.7

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.6

7.7

156

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

7.7

159

990

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.1

7.6

325

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.2

7.6

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.7

7.6

3A149, ,

NOMESCO Finland

25.0

7.6

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

11.8

7.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

7.5

123

719

R11

ICD-10 Finland

Nausea and vomiting

1.5

7.5

234

1597

2BD01, ,

NOMESCO Finland

8.8

7.5

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

6.1

7.5

WX900

NOMESCO Finland

Resuscitation

6.1

7.5

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.3

7.5

243

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

7.5

308

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.5

494

L03AA02

ATC

filgrastim; parenteral

1.8

7.5

105

588

SPAT1211

SPAT

Application of soft bandage

1.4

7.5

275

1941

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.2

7.5

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.3

7.4

238

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.4

2300

21105

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.4

7.4

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

7.3

317

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.4

7.3

208

K92.1

ICD-10 Finland

Melaena

1.6

7.3

177

1145

K05

ICPC

Irregular heartbeat other

1.8

7.3

101

563

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

7.3

257, ,

Kela drug reimbursment

+∞

7.3

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

7.3

131

787

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

10.9

7.3

I97.0

ICD-10 Finland

Postcardiotomy syndrome

6.8

7.3

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.6

7.3

149

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.6

7.2

155

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.0

7.2

366

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

7.2

116

675

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

7.2

115

668

E06.4

ICD-10 Finland

Drug-induced thyroiditis

15.7

7.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

7.2

213

1440

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.2

211

1425

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

7.2

284

2032

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.5

7.2

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

30.0

7.1

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.3

7.1

211

J45

ICD-10 Finland

Asthma

1.4

7.1

267

1892

K22

ICPC

Risk factor cardiovascular disease

1.6

7.1

180

1177

N25.0

ICD-10 Finland

Renal osteodystrophy

6.6

7.1

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

12.0

7.1

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

7.1

165

1059

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

5.6

7.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

7.0

364

2724

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

7.0

323

K70.4

ICD-10 Finland

Alcoholic hepatic failure

3.6

7.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

7.0

314

2296

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.0

1283

11207

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.8

6.9

124

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

6.9

405

3089

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

6.9

1161

10050

OAA67, ,

SPAT

0.6

6.9

166

2503

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.2

6.9

239

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.9

6.9

479

XF620

NOMESCO Finland

Examination of circulation with color method

4.0

6.9

J86.9

ICD-10 Finland

Pyothorax without fistula

2.7

6.9

136

N30.0

ICD-10 Finland

Acute cystitis

1.3

6.8

416

3191

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

6.8

111

649

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.1

6.8

293

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.3

6.8

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

6.7

6.8

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

6.8

532

A04

ICPC

Weakness/tiredness general

1.3

6.8

417

3205

T82

ICPC

Obesity

1.8

6.8

540

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.1

6.8

FXG00

NOMESCO Finland

Insertion and use of IABP

16.7

6.7

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

4.3

6.7

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

0.4

6.7

893

ZXE90

NOMESCO Finland

More than 22 hours

3.5

6.7

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.1

6.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

6.7

439

3406

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.3

6.7

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.5

6.7

168

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

6.6

195

1317

I51.9

ICD-10 Finland

Heart disease, unspecified

12.2

6.6

R53

ICD-10 Finland

Malaise and fatigue

1.3

6.6

699

5765

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.8

6.6

494

SPAT1283

SPAT

Restricted health certificate

1.4

6.5

324

2411

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

6.5

272

Z2445

NOMESCO Finland

Psychologist

1.8

6.5

562

FM2CE, ,

NOMESCO Finland

6.2

6.4

R4120

NOMESCO Finland

Occupational therapy

1.5

6.4

195

1326

P15

ICPC

Chronic alcohol abuse

1.8

6.4

519

I44

ICD-10 Finland

Atrioventricular and left bundle-branch block

69.9

6.4

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.9

6.4

3A422, ,

NOMESCO Finland

14.3

6.4

R05

ICPC

Cough

1.3

6.4

689

5691

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.5

6.4

189

1280

R28

ICPC

Limited function/disability (R)

2.3

6.4

184

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

6.4

543

WX720

NOMESCO Finland

Own respiration

1.7

6.3

117

709

N06DA02

ATC

donepezil; oral

0.6

6.3

101

1672

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

6.5

6.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

6.3

132

827

NA3BG, ,

SPAT

0.3

6.3

626

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

6.3

501

TPX15

NOMESCO Finland

Removal of vascular injection port

3.5

6.3

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

18.0

6.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.3

6.3

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

6.3

150

970

A02BC01

ATC

omeprazole; systemic

1.2

6.3

853

7224

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

6.2

283

5244

FHL

Heart transplantation

+∞

6.2

C01DX22

ATC

vericiguat; systemic

+∞

6.2

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

6.2

354

Kela drug reimbursment

Ivabradine

+∞

6.2

ZXH02

NOMESCO Finland

Procedure performed inside intensive care unit

+∞

6.2

N18

ICD-10 Finland

Chronic kidney disease

2.4

6.2

161

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.0

6.2

345

D64.8

ICD-10 Finland

Other specified anaemias

2.1

6.2

277

L30.3

ICD-10 Finland

Infective dermatitis

1.7

6.2

103

607

B05DA

ATC

Isotonic solutions

3.1

6.1

R07.3

ICD-10 Finland

Other chest pain

1.4

6.1

243

1740

306

Kela drug reimbursment

Erythropoietin and darbepoetin

5.7

6.1

A10BB01

ATC

glibenclamide; oral

1.7

6.1

114

694

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.0

6.1

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.1

6.1

246

XX3BW, ,

NOMESCO Finland

12.5

6.1

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

4.1

6.1

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.0

488

3892

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.6

6.0

122

B80

ICPC

Iron deficiency anaemia

2.0

6.0

287

SPAT1312

SPAT

General health counselling

1.2

6.0

942

8084

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

6.0

115

704

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1077

2490

5.46

307.65

5.0

2.4

352.63

150.63

ng/l

25.09

1025

2244

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1579

4338

5.22

307.65

3.1

2.3

2.34

2.27

g/l

5.43

1507

3980

(3022948) Iron [Moles/volume] in Serum or Plasma

1645

4655

5.15

307.65

3.1

2.3

13.50

13.24

umol/l

0.60

1582

4309

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3124

8722

10.96

307.65

6.8

2.4

2378.93

1109.85

ng/l

23.50

2987

7243

(3027456) Digoxin [Moles/volume] in Serum or Plasma

486

554

9.78

307.65

3.2

3.0

0.78

0.79

nmol/l

0.14

398

401

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1551

4044

5.48

307.65

3.1

2.4

22.90

23.60

1.02

1400

3408

(3022217) INR in Platelet poor plasma by Coagulation assay

2799

15620

3.35

299.80

33.3

14.0

1.56

1.29

inr

29.31

888

4387

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

441

754

6.41

249.84

2.0

10.81

11.86

mg/l

1.19

405

693

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2219

11956

2.80

231.77

5.3

2.9

33.66

44.10

ng/l

0.27

1849

8615

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2227

12111

2.77

226.95

3.7

2.6

193.44

163.24

ug/l

1.57

2111

11017

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1645

7813

2.81

215.92

2.7

2.1

3.21

2.95

mg/l

2.78

1462

6538

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

522

1266

4.56

198.19

2.0

1.9

33.01

39.65

u/l

6.63

361

1118

(3020779) Urea [Moles/volume] in Serum or Plasma

852

2937

3.38

195.33

13.5

6.5

11.66

9.71

mmol/l

9.27

821

2779

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1236

5317

2.87

192.24

6.0

3.3

0.81

mmol/l

0.01

1181

4970

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1284

5839

2.72

177.37

5.1

2.9

410.32

137.67

ng/l

1.29

1164

4627

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

438

1094

4.35

159.02

6.0

2.8

0.38

0.35

u/ml

0.66

275

591

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

657

2333

3.15

140.21

2.8

1.9

14.95

5.69

ug/l

4.54

591

1958

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2548

17007

2.26

138.58

8.9

6.6

14.02

12.15

umol/l

8.34

2450

16140

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

852

3614

2.70

130.38

12.2

6.9

5.11

5.14

kpa

0.30

807

3456

(3012544) pH of Venous blood

761

3050

2.82

129.97

5.3

3.6

7.35

7.39

—

(3027801) Oxygen [Partial pressure] in Arterial blood

851

3615

2.69

129.80

12.2

6.9

11.30

12.45

kpa

9.57

804

3454

(3021447) Carbon dioxide [Partial pressure] in Venous blood

748

2979

2.83

129.23

5.3

3.7

5.90

5.82

kpa

1.26

721

2905

(3003458) Phosphate [Moles/volume] in Serum or Plasma

955

4309

2.57

128.71

8.6

5.5

1.08

1.02

mmol/l

8.94

900

3979

(3002032) Base excess in Venous blood by calculation

744

2974

2.82

127.52

5.3

3.7

1.82

1.98

mmol/l

0.48

634

2494

(3000991) Gas panel - Venous blood

697

2731

2.86

123.79

14.6

7.8

—

(3003396) Base excess in Arterial blood by calculation

839

3618

2.64

123.63

12.3

6.9

1.02

0.98

mmol/l

0.07

676

2887

(3016502) Oxygen saturation in Arterial blood

776

3220

2.73

123.46

12.8

7.3

94.61

95.72

3.27

750

3102

(3023368) Bacteria identified in Blood by Culture

1632

9520

2.16

119.40

5.6

4.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2717

19370

2.13

114.93

8.5

4.4

6.89

6.74

mmol/l

3.12

2618

18183

(3014111) Lactate [Moles/volume] in Serum or Plasma

697

2851

2.73

113.33

12.6

6.6

1.45

1.34

mmol/l

1.34

676

2784

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2434

16789

2.06

110.78

11.6

6.5

1.20

1.21

mmol/l

24.81

2067

14200

(3001604) Monocytes [#/volume] in Blood

2355

16080

2.05

109.88

7.7

5.8

0.64

0.60

e9/l

7.69

2060

13734

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

858

3938

2.48

109.72

7.5

4.3

259.49

240.07

u/l

2.45

815

3709

(3006315) Basophils [#/volume] in Blood

2357

16126

2.04

109.02

7.7

5.8

0.04

e9/l

0.01

2060

13773

(3013115) Eosinophils [#/volume] in Blood

2409

16632

2.04

108.39

8.2

6.0

0.19

e9/l

2.00

2120

14369

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2257

15245

2.03

107.72

11.0

5.8

1.20

1.21

mmol/l

20.92

2129

13766

(3019198) Lymphocytes [#/volume] in Blood

2391

16503

2.03

107.18

7.8

5.9

1.72

1.94

e9/l

6.87

2120

14379

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1058

5390

2.28

106.27

2.1

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

449

1544

3.13

99.66

5.9

4.2

23.98

24.16

mmol/l

0.51

440

1517

(40760892) CBC W Ordered Manual Differential panel - Blood

2218

15169

1.97

99.02

8.6

6.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

681

2957

2.55

97.06

14.2

7.7

122.51

122.18

g/l

0.13

668

2875

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1167

6433

2.12

94.63

4.2

1.7

1.74

1.42

mg/l

1.51

954

4934

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

514

1993

2.80

91.57

15.7

8.6

1.43

1.36

0.92

508

1982

(3024354) Oxygen [Partial pressure] in Venous blood

584

2426

2.63

90.82

4.7

3.1

4.64

kpa

0.02

558

2358

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

510

1985

2.78

90.14

16.2

8.7

0.62

0.66

0.77

505

1974

(3013650) Neutrophils [#/volume] in Blood by Automated count

2551

18734

1.91

87.34

11.4

9.4

4.47

4.15

e9/l

8.81

2248

16197

(3018677) aPTT in Platelet poor plasma by Coagulation assay

928

4817

2.19

86.85

5.1

2.0

31.57

29.77

10.29

901

4658

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

424

1530

2.97

86.07

3.6

3.3

4.32

4.47

pmol/l

1.71

396

1340

(3006504) Eosinophils/100 leukocytes in Blood

2173

15203

1.88

85.96

8.2

6.1

2.65

2.88

5.03

2080

14092

(3019069) Monocytes/100 leukocytes in Blood

2181

15291

1.88

85.56

8.5

6.4

9.02

8.83

1.94

2089

14202

(3022096) Basophils/100 leukocytes in Blood

2120

14765

1.87

84.57

8.3

6.1

0.65

0.67

1.03

2029

13678

(3002030) Lymphocytes/100 leukocytes in Blood

2212

15663

1.86

83.23

8.3

6.2

24.06

27.33

37.19

2122

14581

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

407

1495

2.90

79.81

1.8

1.7

1.56

1.54

g/l

0.13

335

1278

(3024561) Albumin [Mass/volume] in Serum or Plasma

2081

14600

1.84

79.24

5.9

4.9

34.13

35.20

g/l

13.63

1949

13456

(3027945) Reticulocytes/100 erythrocytes in Blood

759

3767

2.24

78.63

2.7

2.6

1.91

1.70

5.83

684

3286

(3018418) pH of Serum or Plasma

1537

9840

1.88

78.23

5.8

3.9

7.40

0.49

369

1833

(3018010) Neutrophils/100 leukocytes in Blood

2160

15425

1.82

76.67

8.0

5.9

60.55

57.45

27.51

2067

14359

(3020630) Protein [Mass/volume] in Serum or Plasma

622

2869

2.37

76.45

2.4

2.6

64.40

66.35

g/l

6.54

576

2564

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

729

3640

2.21

74.03

2.0

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

439

1763

2.66

72.34

16.8

8.6

24.23

24.33

mmol/l

0.23

423

1716

(3019060) Gas panel - Arterial blood

475

2002

2.54

70.84

6.2

4.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

725

3677

2.17

70.51

1.9

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3160

25724

1.91

69.49

11.2

7.6

80.99

79.68

u/l

0.88

3038

24109

(3021589) Normoblasts [#/volume] in Blood

1993

14305

1.74

65.85

14.8

9.4

0.00

e9/l

0.06

1647

11626

(3042936) Bacteria identified in Isolate by Culture

856

4745

2.01

65.11

2.5

2.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1371

8879

1.80

64.38

3.7

2.7

2502.32

5316.56

umol/l

2.50

1213

7715

(3044889) 12 lead EKG panel

2907

23304

1.79

64.06

6.9

3.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

180

467

3.98

61.20

1.5

1.4

28.07

33.93

g/l

6.88

147

429

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

261

866

3.14

60.88

5.7

2.8

3.63

3.59

g/l

0.11

252

822

(3004119) Hemoglobin [Mass/volume] in Venous blood

433

1889

2.44

59.56

4.9

3.0

129.54

130.54

g/l

0.35

416

1848

(3042733) HLA Ab [Presence] in Serum

8.75

59.39

5.1

4.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

118

7.41

59.23

33.0

37.7

7.88

7.32

ug/l

1.44

111

(3020891) Body temperature

320

1214

2.77

58.61

6.1

4.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

429

1886

2.42

57.96

9.5

6.7

24.52

24.65

mmol/l

0.24

405

1798

(3033658) Prothrombin time (PT) actual/Normal

1295

8490

1.76

56.86

6.0

4.0

73.06

88.30

59.12

1266

8309

(3023520) Reticulocytes [#/volume] in Blood

567

2834

2.15

56.34

2.8

2.6

72.30

66.97

e9/l

2.37

418

2155

(3009445) Proteinase 3 Ab [Units/volume] in Serum

345

1390

2.61

56.05

1.5

16.08

17.69

u/ml

—

(40758558) Short blood count panel - Blood

1249

8215

1.74

53.60

9.6

7.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1426

9732

1.70

53.44

2.6

2.1

214.19

225.83

u/l

0.20

1352

9102

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

447

2075

2.29

53.14

5.5

3.7

2.29

1.69

mmol/l

2.38

347

1505

(3022493) Free Hemoglobin [Mass/volume] in Plasma

110

7.10

51.16

26.8

1.5

99.51

72.82

mg/l

0.48

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

456

2172

2.23

50.86

5.7

3.8

5.27

5.15

kpa

1.84

438

2037

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1459

10127

1.67

50.66

3.7

3.3

46.59

36.17

u/l

1.42

1392

9556

(3009343) pH of Capillary blood

451

2143

2.23

50.59

5.7

3.8

7.41

7.42

0.69

225

(3037522) Nuclear Ab [Titer] in Serum

678

3769

1.95

49.89

1.3

520.92

504.35

titre

0.07

130

754

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

389

1748

2.35

49.77

19.1

9.3

—

(3013512) EKG study

1428

9906

1.67

49.41

6.3

3.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

276

1060

2.71

49.22

5.4

3.9

1.45

1.33

mmol/l

0.91

271

1049

(3023199) Leukocytes [#/volume] in Pleural fluid

154

421

3.75

48.60

1.5

1.4

9627.63

2400.12

e6/l

0.54

100

304

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

602

3243

2.00

48.41

2.2

2.4

0.20

0.21

g/l

3.93

548

3027

(3024932) HLA-DR beta [Type]

7.52

48.27

1.1

—

(3024928) Oxygen saturation in Venous blood

194

621

3.22

47.96

5.5

3.0

—

(3024471) HLA-A [Type]

7.44

47.82

1.0

—

(3012441) Differential panel - Pleural fluid

142

372

3.91

47.61

1.5

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

347

1517

2.40

47.18

4.1

3.1

25.00

25.26

mmol/l

0.58

334

1472

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

173

523

3.40

46.90

1.6

1.3

245.17

277.92

u/ml

0.91

128

316

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

316

1338

2.47

46.07

2.1

1.9

6.53

2.81

ug/l

0.38

281

1157

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

403

1905

2.23

45.61

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

231

842

2.84

45.47

6.0

2.7

213.84

193.14

2.97

226

798

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

180

570

3.25

45.29

1.5

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

273

1091

2.60

44.92

1.6

1.5

160.00

326.36

titre

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

269

1072

2.61

44.51

3.2

3.3

51.95

56.88

mg/l

0.11

216

884

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

246

939

2.72

44.34

7.5

2.3

87.93

90.51

1.02

241

909

(3034860) Kappa light chains.free [Mass/volume] in Serum

269

1075

2.60

44.25

3.2

3.3

55.78

56.41

mg/l

0.02

218

882

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

253

983

2.67

44.04

1.8

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

468

2378

2.09

43.99

2.5

2.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

263

1045

2.61

43.77

3.1

3.3

4.05

2.26

ratio

0.28

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2813

23404

1.60

43.29

4.4

3.6

15.53

14.88

pmol/l

29.44

2588

20865

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

213

765

2.88

43.07

1.7

—

(3010421) pH of Blood

221

812

2.81

42.84

5.1

4.2

7.42

0.06

194

730

(3028308) Erythrocytes [#/volume] in Pleural fluid

138

387

3.65

41.96

1.5

1.4

31451.54

79498.93

e6/l

1.28

222

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

111

269

4.21

41.39

2.4

—

(40767503) Oxygen content in Capillary blood by calculation

185

629

3.03

41.27

3.3

2.4

16.59

16.35

0.29

102

322

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

204

4.74

41.25

1.6

1.5

14.87

13.24

umol/l

1.42

188

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

109

262

4.24

41.08

1.2

—

(3045788) Cell count panel - Pleural fluid

123

324

3.88

40.94

1.6

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

150

452

3.40

40.87

8.6

6.4

10.97

11.75

mg/l

1.28

139

421

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

203

736

2.84

40.33

1.7

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

267

1112

2.49

40.25

4.3

2.1

446.39

616.73

ug/l

0.40

256

1049

(1616796) Gas panel - Central venous blood

191

672

2.93

40.09

4.9

3.7

—

(3044640) Blood type and Crossmatch panel - Blood

1439

10401

1.58

40.07

3.1

2.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

175

588

3.06

39.85

1.8

1.4

—

(3036489) Thrombin time

272

1149

2.46

39.76

5.7

2.1

21.95

21.26

1.10

261

1025

(3012501) Base excess in Blood by calculation

192

683

2.89

39.50

4.9

4.4

2.77

2.60

mmol/l

0.29

133

463

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

164

534

3.15

39.40

1.9

1.5

109.36

120.36

u/ml

0.39

102

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1410

10194

1.57

38.97

3.3

2.6

57.64

68.60

u/l

0.76

1328

9393

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

224

879

2.63

38.18

4.9

3.8

1.90

1.46

mg/l

9.63

209

800

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

635

2.91

37.60

9.1

5.5

768.07

2743.19

iu/ml

0.41

(3023183) Ammonium ion [Moles/volume] in Plasma

196

725

2.78

37.50

2.8

3.0

32.22

36.32

umol/l

1.31

182

649

(3048929) Epstein Barr virus Ab [Presence] in Serum

203

767

2.73

37.29

1.5

1.3

—

(3021901) Oxygen saturation in Capillary blood

165

560

3.02

36.92

3.5

2.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

105

269

3.97

36.35

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

563

3247

1.85

36.17

1.8

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1144

7989

1.59

36.16

3.0

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

446

2384

1.97

36.12

5.3

3.7

117.75

86.15

ng/l

7.79

402

2019

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

6.70

36.03

2.6

2.3

224.11

163.76

3.41

(40768806) Pleura Pathology biopsy report

128

380

3.44

35.72

1.5

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

525

2987

1.86

35.17

1.9

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

137

5.25

34.92

30.0

22.8

127.43

117.84

ug/l

0.44

114

(3007853) Bacteria identified in Skin by Aerobe culture

626

3776

1.77

34.54

2.2

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

378

1954

2.02

33.58

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

112

320

3.56

33.15

1.3

6.33

6.12

mmol/l

0.33

102

297

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

431

2344

1.93

33.07

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

160

568

2.89

33.05

1.7

1.9

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

115

5.54

32.93

4.3

2.1

16.63

90.94

ug/l

0.54

101

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1901

15041

1.48

32.65

3.2

2.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

199

800

2.56

32.27

1.7

1.5

0.23

g/l

0.32

185

756

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

204

830

2.53

32.27

1.8

1.5

1.15

1.17

g/l

0.56

192

782

(3009871) Measles virus Ab [Titer] in Serum

6.69

32.23

1.2

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

108

308

3.57

32.07

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

599

3645

1.75

31.88

2.8

2.9

10.08

9.45

umol/l

0.30

532

3216

(3002582) Erythrocytes [#/volume] in Urine

1408

10558

1.50

31.21

3.8

3.3

176.87

93.82

e6/l

0.45

1122

8092

(3006184) Hemoglobin [Mass/volume] in Capillary blood

182

722

2.59

30.34

2.7

2.0

133.08

130.01

g/l

0.70

125

484

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

388

2098

1.93

30.19

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

145

513

2.89

30.15

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

145

513

2.89

30.15

1.7

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

193

797

2.49

29.58

3.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3594

32720

1.66

29.14

26.3

14.1

24.76

26.38

mg/l

2.51

3236

25880

(3022313) Gas panel - Capillary blood

316

1615

2.03

28.88

6.2

3.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

127

429

3.02

28.69

1.5

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1105

7992

1.52

28.65

1.7

1.5

18.94

20.38

nmol/l

2.44

966

6732

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

127

437

2.96

27.78

1.5

1.2

4.27

3.65

u/ml

0.28

202

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

129

448

2.94

27.76

1.5

1.2

4.21

3.81

u/ml

0.08

151

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3275

29276

1.53

27.65

5.4

4.3

2.09

2.18

mu/l

0.37

3039

26248

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

143

529

2.76

27.38

1.4

1.5

—

(3018095) Leukocytes [#/volume] in Urine

1536

11964

1.44

27.02

4.5

3.8

99.94

91.98

e6/l

0.13

1169

8610

(3000850) Epithelial cells [#/volume] in Urine

1011

7255

1.52

26.94

3.1

2.6

4.65

4.50

e6/l

0.17

925

6495

(3030467) Casts [#/volume] in Urine by Automated count

1277

9618

1.47

26.75

3.7

3.2

0.70

0.43

e6/l

2.87

1001

7291

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

559

3494

1.69

26.68

4.4

3.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2523

21516

1.43

26.63

5.0

4.4

1691.12

2362.66

e6/l

0.24

316

(3013707) Erythrocyte sedimentation rate by Westergren method

2782

24156

1.44

26.55

5.1

3.9

15.92

12.41

mm/h

19.68

2600

22163

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

110

358

3.12

26.51

1.6

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

624

4023

1.64

26.42

1.9

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

7.60

26.28

1.5

1.2

79.52

89.53

0.59

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

134

490

2.79

26.23

4.3

3.2

355.22

3253.14

u/ml

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.85

26.12

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

156

619

2.58

26.01

1.3

1.2

176.00

112.00

titre

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1379

2.05

25.73

2.2

3.77

3.68

g/l

0.45

248

1229

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1382

2.04

25.57

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1383

2.04

25.52

2.3

2.2

7.22

7.32

g/l

0.40

249

1227

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

7.55

25.42

1.5

1.2

78.96

89.38

0.59

(3005719) IgG [Mass/volume] in Serum or Plasma

398

2300

1.80

24.99

3.0

2.7

10.68

10.46

g/l

0.34

372

2079

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

119

422

2.87

24.68

1.4

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1367

10561

1.43

24.55

3.5

3.2

7.18

7.90

mmol/l

8.25

1152

8808

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

176

760

2.37

24.48

1.7

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1292

2.04

24.17

2.3

3.07

2.94

g/l

1.26

231

1142

(40757494) Bilirubin.total [Moles/volume] in Blood

155

4.17

23.98

2.3

2.1

24.84

23.27

umol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.68

23.76

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

245

1225

2.06

23.73

3.0

2.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

911

6548

1.50

23.65

1.8

1241.39

1136.50

nmol/l

2.23

719

4796

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

215

1028

2.15

23.42

2.2

0.01

0.04

g/l

1.13

196

936

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

100

332

3.06

23.33

1.3

791.58

367.94

u/l

0.41

317

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

272

1423

1.97

23.21

6.7

4.2

25.11

24.77

mmol/l

0.99

256

1303

(3012516) Albumin [Mass/volume] in Urine

1308

10104

1.43

23.21

3.6

3.2

273.11

400.15

mg/l

0.68

918

6483

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

177

787

2.30

23.03

1.6

1.5

—

(3026008) Bacteria identified in Urine by Culture

1251

9604

1.43

22.91

3.3

3.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

237

1186

2.06

22.90

2.7

2.3

0.60

1.02

g/l

1.30

203

1004

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

289

3.19

22.89

3.0

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1361

10624

1.41

22.63

4.2

3.8

12.63

8.04

mg/mmol

2.90

952

6713

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

173

773

2.29

22.25

1.4

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1289

2.00

22.24

2.3

10.21

10.35

g/l

0.19

224

1132

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

266

3.24

21.91

1.2

1.3

15.32

13.22

u/l

0.15

247

(36304419) Bacteria [Presence] in Urine

1211

9315

1.42

21.70

3.7

3.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

7.42

21.59

1.2

1.1

58.49

2110.86

ng/l

0.48

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

7.15

21.58

6.4

7.6

—

(3035880) pH of Pleural fluid

186

3.70

21.57

1.3

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

316

1780

1.84

21.51

1.9

1.29

1.40

g/l

0.33

293

1595

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

438

2717

1.68

21.29

5.0

3.7

1.21

1.23

mmol/l

4.88

412

2354

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

159

699

2.32

21.25

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

159

699

2.32

21.25

1.4

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

330

2.95

21.11

1.6

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

330

2.95

21.11

1.6

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

195

936

2.13

21.04

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1710

14002

1.37

20.88

2.1

2.0

92.96

93.47

pmol/l

0.16

976

7365

(3034426) Prothrombin time (PT)

100

4.74

20.74

1.5

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

429

2.68

20.64

1.4

1.5

—

(3026782) Osmolality of Urine

945

7013

1.45

20.42

3.3

2.8

529.13

564.20

mosm/kgh2o

5.97

837

6008

(3052851) Hemolysis interference index of Serum or Plasma

198

968

2.09

20.37

4.3

3.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1431

11429

1.38

20.23

3.9

3.6

2.34

2.35

mmol/l

2.46

1247

9902

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

415

2572

1.68

20.21

3.5

2.5

53.95

66.94

ml/min/173m2

9.80

206

980

(3011335) Digoxin [Mass/volume] in Serum or Plasma

8.42

20.10

2.2

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

270

1483

1.87

19.90

2.3

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

165

3.73

19.69

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

327

2.88

19.66

2.2

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

117

464

2.56

19.60

1.4

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

195

963

2.07

19.54

2.3

2.2

0.00

g/l

0.79

176

873

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

191

944

2.07

19.10

2.3

2.2

0.00

g/l

-0.00

175

869

(3019550) Sodium [Moles/volume] in Serum or Plasma

3684

34461

1.54

18.67

35.9

16.0

139.42

139.68

mmol/l

8.07

3641

33492

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

209

1081

1.98

18.44

2.3

2.1

35.89

37.82

g/l

4.10

185

926

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

198

3.37

18.26

1.5

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

6.95

17.78

5.7

8.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3685

34564

1.52

17.45

36.3

16.1

4.06

3.99

mmol/l

54.63

3643

33539

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

104

413

2.55

17.41

1.4

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

5.10

17.37

6.9

6.4

25.87

24.59

mmol/l

0.91

(3037756) Immunofixation for Serum or Plasma

157

750

2.13

17.19

1.5

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

408

2624

1.61

17.09

5.0

4.2

0.11

0.14

0.45

161

890

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

245

1370

1.84

17.06

2.1

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

156

3.56

16.61

21.5

13.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

228

1266

1.84

16.25

6.7

5.0

1.80

1.62

0.93

213

1183

(3017181) Myelocytes/100 leukocytes in Blood

421

2764

1.58

16.14

5.0

4.1

0.93

1.02

0.32

175

1025

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.33

15.88

1.8

2.0

7848.74

2032.47

e6/l

1.63

(3036481) Cortisol [Moles/volume] in Serum or Plasma

414

2719

1.58

15.84

2.7

2.4

379.42

371.62

nmol/l

0.34

390

2488

(3025159) Blasts/100 leukocytes in Blood

382

2463

1.60

15.80

5.0

4.2

0.15

0.24

0.29

135

735

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3377

31302

1.39

15.72

26.7

13.4

72.39

78.86

ml/min/173m2

45.36

3020

25802

(3007930) Methemoglobin/Hemoglobin.total in Blood

222

1237

1.84

15.65

6.7

5.0

0.83

0.88

1.38

207

1157

(3014891) Appearance of Pleural fluid

7.21

15.65

1.4

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

388

2519

1.59

15.59

5.0

4.0

0.84

0.71

0.35

158

888

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

130

3.72

15.52

1.3

69.75

63.51

0.60

105

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

121

2494

0.47

15.44

1.5

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

111

482

2.34

15.35

1.6

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

126

578

2.21

15.31

1.5

1.3

17.99

44.52

u/l

3.23

116

493

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

238

2.93

15.18

1.1

1.2

350.00

118.00

titre

—

(3029937) Albumin [Presence] in Urine by Test strip

1063

8404

1.35

15.10

4.7

3.8

0.01

0.00

estimate

0.20

351

2779

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

281

2.73

14.72

1.8

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

281

2.73

14.72

1.8

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

281

2.73

14.72

1.8

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

366

2.49

14.40

2.2

2.5

1.81

1.39

g/24h

0.43

183

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

144

717

2.04

14.19

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

724

5431

1.40

14.13

1.6

1.5

2.80

2.55

g/l

1.98

470

3174

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

348

2.50

13.92

1.8

1.9

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

4.13

13.89

1.2

1.3

19.71

23.35

0.29

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

+∞

13.54

1.2

0.0

38.08

—

ng/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

160

3.21

13.23

1.8

1.9

—

(3042631) Mycobacterium sp identified in Specimen

108

497

2.20

13.07

2.4

2.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

108

499

2.19

12.95

4.4

2.8

—

(3017569) Oxygen content in Arterial blood

147

3.29

12.95

2.1

2.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

261

2.67

12.83

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

741

5664

1.37

12.80

3.3

3.1

2.89

1.87

e6/l

1.82

403

3086

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

257

2.67

12.67

1.5

1.6

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

106

3.70

12.60

1.3

3.97

2.17

0.73

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

+∞

12.50

1.2

0.0

—

(40768446) Kidney Pathology biopsy report

121

3.49

12.46

1.5

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

772

5966

1.36

12.40

3.1

2.9

1.24

1.04

e6/l

0.61

430

3372

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

159

860

1.88

12.36

1.5

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

922

7326

1.33

12.29

4.2

3.4

—

(21494755) Public health laboratory ask at order entry panel

141

2566

0.53

12.28

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

108

3.63

12.27

2.0

2.2

1129.06

614.88

e6/l

0.40

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1594

0.42

12.18

1.3

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

123

3.44

12.16

2.8

2.2

—

(4200892) Spirometry reversibility

333

2209

1.55

12.15

1.5

1.4

—

(3004451) EKG impression Narrative

3.77

11.96

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

326

2.42

11.84

1.9

2.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

333

2.40

11.77

6.3

24.4

7.35

7.19

mmol/l

0.16

273

(3007566) Smooth muscle Ab [Titer] in Serum

145

775

1.90

11.71

1.2

76.84

85.00

titre

0.25

(3000012) Reticulocyte production index

462

2.17

11.62

2.7

2.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2502

22630

1.26

11.47

4.9

4.2

—

(3051611) Lipemic interference index of Serum or Plasma

340

2.35

11.25

5.1

2.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

102

492

2.10

11.02

1.1

—

(3047181) Lactate [Moles/volume] in Blood

169

967

1.78

10.99

8.1

5.8

1.39

1.29

mmol/l

0.43

149

846

(3033799) Differential panel - Peritoneal fluid

102

3.55

10.98

3.0

1.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

454

2.14

10.92

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3265

30565

1.30

10.91

6.7

5.6

41.53

39.76

mmol/mol

20.32

3049

27851

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

428

3062

1.44

10.77

2.4

2.5

36.91

55.44

u/l

0.61

364

2659

(1761868) Lipid panel - Serum or Plasma

892

10908

0.77

10.74

3.0

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

166

955

1.77

10.61

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

109

549

2.01

10.50

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1503

12926

1.25

10.42

2.6

2.2

74.89

78.10

nmol/l

3.85

1362

11393

(3051651) Icteric interference index of Serum or Plasma

190

2.76

10.40

5.9

3.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

185

2.78

10.35

2.0

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

185

2.78

10.35

2.0

2.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

107

539

2.01

10.31

1.9

4.68

4.86

mmol/24h

0.21

459

(40761535) Cells panel - Urine sediment

381

2693

1.45

10.22

4.3

3.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

101

502

2.03

10.11

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

519

3889

1.38

9.99

1.7

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.80

9.98

4.2

5.8

—

(4035726) Immunohistochemistry procedure

432

3145

1.41

9.85

1.7

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

2989

27817

1.25

9.65

31.6

16.9

15.36

15.07

2.12

2962

27234

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

4.44

9.52

1.3

10.80

6.96

—

(40761536) Microorganisms panel - Urine sediment

379

2716

1.43

9.44

4.7

3.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1791

15832

1.23

9.30

4.2

3.5

0.01

0.00

estimate

0.17

371

2822

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

795

6411

1.29

9.21

3.1

3.3

2.46

2.45

mmol/l

1.09

694

5628

(3044007) Cell count panel - Peritoneal fluid

3.54

9.19

2.2

1.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

1770

15654

1.22

9.08

5.4

4.7

0.00

estimate

0.50

396

2910

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

116

629

1.87

9.05

1.6

1.8

101.12

4.72

iu/l

0.49

206

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.08

8.95

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.31

8.86

1.4

19.82

24.86

0.47

(3035350) Ketones [Presence] in Urine by Test strip

1768

15663

1.22

8.84

4.2

3.5

0.00

estimate

1.94

418

3134

(3025941) Bacteria identified in Stool by Culture

236

1560

1.54

8.79

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

275

2.31

8.77

1.9

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

156

2.77

8.77

1.9

2.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

401

2.06

8.63

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

176

2.63

8.49

1.4

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

176

2.63

8.49

1.4

1.7

—

(3003694) ABO and Rh group [Type] in Blood

1031

8678

1.25

8.27

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

146

874

1.69

8.18

1.7

1.6

26128.05

16663.50

e6/l

0.59

625

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

228

2.38

8.13

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

181

2.56

8.04

1.5

1.6

—

(3003181) Sodium [Moles/volume] in Urine

105

574

1.85

8.03

1.4

1.3

61.66

64.87

mmol/l

0.32

460

(3019977) pH of Arterial blood

170

2.60

7.98

2.5

2.6

7.39

7.42

1.15

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

149

903

1.67

7.98

1.7

1.6

0.08

4.64

iu/ml

0.68

172

(3023419) Bacteria identified in Sputum by Culture

498

1.91

7.92

2.2

2.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.43

7.92

1.0

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

854

7080

1.26

7.77

1.7

33428621.21

27069661.05

pmol/l

0.10

703

5763

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2313

21185

1.20

7.75

3.9

3.1

73.58

52.68

u/l

13.20

2163

19502

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

453

1.94

7.73

1.1

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.68

7.57

3.2

2.0

51.17

55.88

0.16

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

181

2.50

7.54

1.5

1.6

—

(3000492) Spirometry study

400

3006

1.36

7.53

1.6

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

128

759

1.71

7.46

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1152

13244

0.82

7.41

3.7

4.3

23.32

21.69

2.65

537

6644

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

13.35

7.37

3.8

14.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.26

7.36

1.4

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

139

849

1.66

7.26

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

138

842

1.66

7.24

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

827

9814

0.80

7.19

2.8

3.1

0.86

0.79

ug/l

0.66

599

6636

(42529406) Shigella sp [Presence] in Stool by Culture

139

853

1.65

7.13

1.2

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

275

2.16

7.10

1.3

7.38

6.63

g/l

0.70

195

(3021788) Differential panel - Synovial fluid

112

650

1.74

7.07

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

206

2.34

7.02

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.26

6.81

1.1

66.19

88.21

1.84

(3024139) IgG subclass 3 [Mass/volume] in Serum

275

2.12

6.70

1.3

0.49

0.38

g/l

1.15

194

(3028192) IgG subclass 2 [Mass/volume] in Serum

276

2.11

6.64

1.3

3.27

2.86

g/l

0.78

195

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

330

2.01

6.63

3.6

3.0

—

(40761511) CBC panel - Blood by Automated count

3545

34033

1.26

6.62

24.4

13.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

595

4820

1.27

6.51

1.3

1.2

52.58

36.29

iu/ml

1.05

187

1509

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.31

6.44

1.4

1.1

—

(3037121) Protein [Mass/volume] in Urine

179

1198

1.51

6.38

3.4

0.36

0.33

g/l

0.18

102

548

(3015171) Extractable nuclear Ab [Units/volume] in Serum

156

1014

1.56

6.35

1.3

1.2

0.10

0.62

u/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

238

1691

1.43

6.27

1.4

1.3

245.27

264.44

u/ml

0.11

226

1550

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

311

2.01

6.20

1.0

1.2

126.00

69.09

u/l

0.64

275

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.13

6.14

1.1

1.3

56.94

87.71

2.64

(3039000) Anion gap in Blood

111

670

1.67

6.13

10.5

7.0

11.16

11.19

mmol/l

0.03

596

(3018572) Chloride [Moles/volume] in Blood

111

670

1.67

6.13

10.5

7.0

104.94

104.83

mmol/l

0.06

596

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.29

6.12

1.5

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

175

2.35

6.11

1.1

1.3

25.14

22.19

u/l

0.25

145

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1963

17940

1.17

6.11

2.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3235

30830

1.21

6.10

4.4

3.8

1.43

1.31

mmol/l

13.98

2995

27609

(4062490) Immunoglobulin typing, IgG

279

2.06

6.10

1.2

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

146

2.48

6.00

2.3

2.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

527

4251

1.27

5.96

13.1

6.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

101

600

1.70

5.93

1.2

—

25.16

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

178

2.31

5.90

1.1

1.3

97.91

87.73

u/l

0.25

151

(3015736) pH of Urine

1404

12513

1.18

5.87

3.9

3.2

5.77

5.76

0.05

860

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.01

5.86

9.7

12.5

4.87

6.08

mmol/l

1.16

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

473

3779

1.28

5.78

1.8

1.70

1.51

4.11

402

3281

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

362

1.89

5.76

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

327

1.94

5.75

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

286

2.00

5.73

1.7

1.3

22.80

27.20

iu/ml

—

(3019225) pH of Specimen

456

3632

1.29

5.71

6.0

4.4

—

(3047189) Immunofixation for 24 hour Urine

150

2.41

5.68

1.9

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

221

2.14

5.61

2.8

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

145

2.42

5.60

2.3

2.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

145

2.42

5.60

2.3

2.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.40

5.57

1.3

1.1

0.97

2.32

mmol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.99

5.51

1.3

2.1

—

(4034850) Laboratory test

149

992

1.52

5.49

18.2

8.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.62

5.47

1.4

1.2

27.22

796.56

u/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.07

5.43

2.7

3.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

960

0.51

5.33

1.9

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

580

1.67

5.33

1.2

1.60

4.52

u/ml

—

(3011412) CD3 cells [#/volume] in Blood

315

1.92

5.32

2.9

2.5

0.90

1.17

e9/l

2.14

282

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.72

5.25

2.5

2.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

243

2.03

5.12

2.4

518.27

593.65

e6/l

0.59

237

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

237

2.04

5.08

2.4

16.35

15.63

0.15

227

(3019832) Treponema pallidum Ab [Presence] in Serum

199

1428

1.41

5.02

1.5

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

431

1.75

5.01

1.3

1.5

—

(40768797) Stomach Pathology biopsy report

532

4383

1.24

5.01

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

178

1253

1.44

5.00

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

124

812

1.54

4.97

2.0

2.1

98.92

96.23

ug/min

0.04

468

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

117

2.49

4.94

1.5

2.0

75.25

109.75

umol/l

0.75

(21494814) CD8 cells/100 lymphocytes in Specimen

117

2.49

4.94

2.2

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

233

2.03

4.93

1.1

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

5.01

4.93

6.6

6.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

419

1.75

4.91

1.3

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.01

4.90

1.3

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

118

2.47

4.85

1.2

1.1

0.64

0.44

g/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

327

1.85

4.79

1.4

1.3

22049.10

94200.22

e6/l

1.64

229

(3025468) Yersinia sp identified in Specimen by Organism specific culture

423

1.74

4.76

1.3

1.5

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

3.41

4.73

1.6

1.3

63.92

130.27

ug/l

2.07

(3024522) Salmonella sp identified in Specimen by Organism specific culture

424

1.73

4.72

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

424

1.73

4.72

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

425

1.73

4.69

1.3

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

471

1.69

4.66

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

274

1.91

4.61

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

110

714

1.55

4.61

1.3

1.2

2.57

2.96

u/ml

0.17

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

111

723

1.55

4.58

1.3

1.2

4.59

6.83

u/ml

0.38

112

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3329

32038

1.18

4.56

5.3

4.6

6.24

5.99

mmol/l

18.75

3051

28744

(3037692) Legionella sp identified in Specimen by Organism specific culture

128

2.35

4.56

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

8.19

4.55

2.3

—

(3012565) Volume of 24 hour Urine

147

2.25

4.55

1.9

2.5

1825.71

2075.95

0.65

124

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

710

6082

1.20

4.53

1.2

1.40

2.06

u/ml

0.97

167

1495

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

363

1.77

4.51

1.6

2.4

488.51

3375.60

u/l

1.40

133

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

105

679

1.56

4.48

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

578

1.60

4.44

1.8

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.69

4.40

1.0

1.2

—

(3036603) Volume of Urine

216

2.00

4.39

1.4

1.7

2006.84

1869.56

0.44

210

(3024980) IgG subclass 4 [Mass/volume] in Serum

473

1.66

4.34

1.5

1.7

0.85

0.87

g/l

0.06

371

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.25

4.31

1.0

1.1

24.29

22.75

u/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

414

1.70

4.28

5.5

4.2

—

(3044941) Cell count panel - Synovial fluid

568

1.60

4.28

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

106

698

1.53

4.20

1.3

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

159

2.15

4.19

3.3

3.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

404

1.69

4.11

1.4

1.5

63.67

58.94

0.43

258

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

590

1.57

4.11

1.2

1.3

174.76

203.66

miu/ml

0.29

220

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

354

1.73

4.01

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

136

952

1.44

4.01

5.3

1.7

6.07

4.03

mg/l

0.84

126

701

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.76

4.00

1.2

2.0

6.92

8.14

mmol/l

—

(3014271) Vancomycin [Susceptibility]

210

1.96

3.99

3.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

105

701

1.51

3.93

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

357

1.72

3.91

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

241

1.87

3.86

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

157

2128

0.73

3.77

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3337

32254

1.16

3.75

4.8

4.2

4.35

4.69

mmol/l

66.83

3114

29357

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1312

11963

1.14

3.67

4.6

3.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

631

1.52

3.66

3.5

3.7

1.69

1.65

0.04

546

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

297

1.76

3.65

1.1

1.5

32.39

29.49

0.28

181

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

537

1.55

3.61

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

197

1.94

3.61

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

170

2.01

3.57

1.4

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

170

2.01

3.57

1.4

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

130

2.16

3.56

2.4

2.9

—

(40768795) Lymph node Pathology biopsy report

338

1.69

3.52

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

204

1563

1.32

3.50

2.6

2.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3306

31985

1.15

3.46

4.8

4.2

1.30

1.44

mmol/l

65.35

3070

28921

(3029075) Extractable nuclear Ab panel - Serum

2.44

3.37

1.1

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.44

3.37

1.6

2.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.58

3.37

1.3

1.1

1.72

1.79

mmol/l

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3616

35240

1.18

3.35

16.0

10.3

28.96

26.89

u/l

3.00

3521

33776

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

189

1.91

3.32

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

189

1.91

3.32

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.67

3.21

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.67

3.21

2.3

4.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

379

1.62

3.18

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

663

1.46

3.11

3.4

1.7

1.12

0.83

nmol/l

2.95

554

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

346

0.40

3.11

1.0

1.4

179.78

196.20

pmol/l

0.17

346

(3001019) Free T4 and TSH panel - Serum or Plasma

1163

0.67

3.10

1.4

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

223

1.80

3.09

1.4

1.5

—

(3045142) Bone marrow Pathology biopsy report

393

1.58

3.00

1.3

—

(3044927) Protein electrophoresis panel - Urine

370

1.60

2.99

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

211

1.81

2.98

1.4

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

220

1.78

2.92

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

1157

0.68

2.88

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1541

16462

0.90

2.87

4.2

5.1

2.79

3.91

ug/l

1.85

1358

14807

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.67

2.86

1.3

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.59

2.86

2.4

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

268

1.68

2.80

1.2

1.3

1.66

1.39

nmol/l

0.85

245

(3006442) Creatine [Moles/volume] in Serum or Plasma

223

1.75

2.80

1.9

1.4

97.28

89.10

umol/l

0.64

223

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

117

2.06

2.76

1.5

—

1550450.00

iu/ml

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

124

2.02

2.75

1.3

1.7

2.81

8.65

nmol/l

0.98

108

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

210

1.77

2.73

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

188

1.81

2.73

1.5

3.65

7.48

u/l

1.98

149

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.00

2.72

1.1

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.00

2.72

1.6

5.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.00

2.72

1.6

4.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.24

2.72

1.1

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

233

1.72

2.70

3.0

2.5

405.03

540.77

e6/l

1.04

197

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

111

810

1.38

2.70

1.3

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.45

2.68

1.3

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

415

1.52

2.62

1.4

1.3

0.20

0.32

nmol/l

0.52

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

361

1.56

2.57

3.8

—

(21494434) Karyotype in Bone marrow

306

1.61

2.57

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

747

6712

1.14

2.54

4.8

3.8

1.01

1.02

kg/l

2.31

996

(3017446) Testosterone [Moles/volume] in Serum or Plasma

292

3471

0.83

2.50

2.3

2.2

11.70

13.16

nmol/l

2.33

262

3104

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.81

2.46

1.1

1.0

—

(3049233) Organic acids panel - Urine

6.25

2.37

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.06

2.36

2.8

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.06

2.36

2.8

2.3

—

(1002224) Polysomnography panel

1261

0.73

2.36

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.03

2.35

2.9

2.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

161

1.80

2.34

1.2

1.3

1.49

1.16

nmol/l

0.49

125

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.82

2.33

1.8

1.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

119

1.94

2.29

1.1

1.3

70.11

624.36

ug/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

405

1.49

2.27

3.4

2.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3390

33086

1.12

2.27

5.3

4.7

2.57

2.80

mmol/l

44.21

3158

29944

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.02

2.25

1.4

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

374

1.50

2.24

1.1

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

114

864

1.33

2.23

1.5

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

385

3337

1.17

2.19

2.1

2.3

145.72

155.15

ug/g

0.23

297

2651

(4281824) Cell count and differential, peritoneal fluid

280

1.58

2.18

1.5

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

211

1.66

2.15

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

211

1.66

2.15

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

211

1.66

2.15

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

122

1.89

2.15

1.1

4.13

4.41

u/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.29

2.15

1.0

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

250

1.60

2.14

1.6

1.3

1.31

1.28

promille

0.04

190

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.78

2.13

1.6

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.78

2.13

1.6

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.78

2.13

1.6

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

102

1.96

2.09

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.00

2.07

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

366

1.48

2.04

1.3

—

nmol/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

154

1.76

2.03

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

223

1.62

2.01

2.5

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

133

1.81

1.98

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

209

1.63

1.96

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

209

1.63

1.96

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

209

1.63

1.96

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

511

4563

1.14

1.94

1.3

1.2

12.58

14.99

u/ml

0.32

200

1647

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

164

1.71

1.93

2.3

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

158

1.71

1.88

1.7

2.5

8.80

10.21

umol/l

0.20

103

(3024263) Appearance of Synovial fluid

197

1.63

1.85

1.1

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.53

1.83

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

236

2770

0.84

1.82

1.3

1.4

—

(3017704) Immunofixation for Urine

191

1.63

1.80

1.9

1.7

—

(40768443) Skin Pathology biopsy report

179

1483

1.21

1.75

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

124

1.78

1.75

1.3

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.33

1.74

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.13

1.71

1.5

1.2

—

(3004775) Volume in Urine collected for unspecified duration

266

1.51

1.70

2.0

689.61

626.12

0.29

157

(3017732) Neutrophils [#/volume] in Blood

260

2241

1.17

1.65

3.2

5.09

5.12

e9/l

0.02

194

1724

(3016750) Collection duration of Urine

188

1.60

1.65

2.1

1.9

484.77

477.95

min

0.12

129

(3035637) Corticotropin [Mass/volume] in Plasma

435

1.38

1.64

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

114

1420

0.80

1.63

2.8

3.7

539.76

2068.29

u/ml

0.94

1228

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.84

1.61

1.2

1.1

903.06

1499.40

miu/ml

2.02

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.14

1.60

1.1

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.50

1.59

1.0

1.3

—

mmol/l

—

(3002619) Bacteria identified in Specimen by Culture

2.06

1.59

1.4

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

1.58

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.00

1.58

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.69

1.58

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

821

0.74

1.57

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

152

1.65

1.55

2.0

2.1

32.00

114.50

ug/min

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.85

1.55

1.1

1.6

1.58

3.81

ug/l

—

(3025130) Human papilloma virus identified in Specimen

176

1.59

1.53

1.8

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.33

1.52

5.6

5.8

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.33

1.52

3.4

2.9

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.33

1.52

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.33

1.52

2.0

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

399

1.38

1.51

4.7

3.7

56.80

55.04

0.30

328

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

225

1.51

1.50

1.3

1088.33

267.83

titre

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

186

1.56

1.47

1.5

1.3

0.76

1.82

u/ml

0.79

114

(3000570) Elastase.pancreatic [Mass/mass] in Stool

123

1001

1.23

1.47

1.4

249.25

271.66

ug/g

0.60

596

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.73

1.43

2.3

1.9

0.70

0.69

umol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

103

826

1.25

1.42

2.7

3.8

236.67

742.38

u/ml

0.80

759

(36660697) Celiac disease serology panel - Serum

254

2222

1.15

1.37

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.20

1.36

1.8

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.61

1.36

2.8

2.7

—

(3000060) B lymphocytes [#/volume] in Blood

1.80

1.36

2.6

2.2

100.00

1620.75

e6/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

190

1.53

1.36

1.4

1.2

10.19

9.46

mmol/l

0.31

183

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.94

1.35

1.0

1.3

—

(3019174) dRVVT (LA screen)

2.94

1.35

1.2

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

264

1.44

1.35

1.9

1.6

22.71

27.87

u/ml

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.97

1.32

1.0

1.1

11.18

5.36

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

1.81

1.30

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

259

1.43

1.28

1.4

29.07

27.11

u/l

0.13

211

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.88

1.28

1.2

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

166

1938

0.85

1.28

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

439

1.32

1.27

2.2

1.9

40.36

27.57

mg/l

0.42

102

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.04

1.21

2.8

1.5

148.20

125.33

ng/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

479

1.30

1.19

1.6

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.83

1.19

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.83

1.19

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.83

1.19

1.1

—

(40757373) Influenza virus identified in Isolate

1.83

1.19

1.4

1.6

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.83

1.19

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.11

1.18

1.4

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.88

1.17

1.5

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.50

1.15

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

300

1.37

1.13

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.38

1.09

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.38

1.09

1.2

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

128

1.56

1.07

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.12

1.05

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

199

1751

1.14

1.04

2.5

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

3699

36559

1.09

1.04

40.7

20.7

40.14

40.73

2.06

3528

33986

(3022145) Colonoscopy Study observation

405

3722

1.10

1.00

1.3

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

205

1.42

1.00

2.9

45.15

37.02

1.19

118

(3007461) Platelets [#/volume] in Blood

3699

36572

1.08

0.99

39.3

20.7

232.62

243.91

e9/l

20.31

3625

35476

(3026389) Candida sp identified in Specimen by Organism specific culture

352

1.31

0.98

1.4

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

783

1.20

0.98

1.5

1.4

12.80

8.35

u/l

1.72

627

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

175

0.57

0.98

1.4

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

148

1.49

0.97

1.0

1.2

1.08

1.05

ratio

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.97

0.0

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.94

0.97

2.0

1.5

—

(3035941) MCH [Entitic mass]

3700

36592

1.08

0.95

39.1

20.6

30.44

30.45

0.12

3661

35935

(3024731) MCV [Entitic volume]

3700

36593

1.08

0.95

39.1

20.6

92.28

91.27

30.72

3661

35938

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

174

1.44

0.94

1.4

1.5

—

(3026361) Erythrocytes [#/volume] in Blood

3700

36596

1.08

0.94

39.3

20.7

4.42

4.53

e12/l

25.03

3624

35379

(3000034) Microalbumin [Mass/volume] in Urine

311

1.32

0.94

3.2

3.1

132.80

63.09

mg/l

0.50

238

(3045424) Erythrocytes [Presence] in Urine

569

1.23

0.94

1.4

—

(3010813) Leukocytes [#/volume] in Blood

3700

36597

1.08

0.94

39.3

20.7

7.17

6.73

e9/l

19.37

3629

35371

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

320

1.31

0.93

1.3

—

(3017509) Phencyclidine [Presence] in Urine

2.22

0.93

2.0

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

2.22

0.93

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

338

1.30

0.93

2.2

3.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

507

1.24

0.92

1.1

180.60

1127.75

iu/ml

—

116

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

167

1.44

0.91

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

348

1.29

0.91

1.1

2.38

2.22

u/ml

0.08

140

(3000963) Hemoglobin [Mass/volume] in Blood

3700

36605

1.08

0.91

39.6

20.8

133.60

136.98

g/l

28.06

3664

35958

(3023511) Choriogonadotropin [Units/volume] in Urine

151

1.46

0.90

1.5

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

127

1.50

0.88

2.6

2.4

27.63

29.48

0.25

116

(3036180) Methadone [Presence] in Urine

111

1.53

0.87

1.8

3.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.86

0.87

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.00

0.87

2.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

149

1690

0.88

0.85

3.5

3.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

1.49

0.85

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.93

0.84

4.7

5.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.74

0.82

1.0

5.31

9.12

mg/g

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

978

0.84

0.80

1.9

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

164

0.61

0.80

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

164

0.61

0.80

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

164

0.61

0.80

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

164

0.61

0.80

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

147

1.43

0.79

1.4

9.45

8.24

ug/l

0.14

133

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

312

1.28

0.78

1.3

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.56

0.77

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.77

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.76

0.76

1.3

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.76

0.76

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

107

1.50

0.75

4.0

2.8

—

(3051101) Glucose [Moles/volume] in Cord blood

1.69

0.75

6.9

7.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.70

0.75

1.1

1.2

51.46

47.28

mg/l

—

(40768441) Liver Pathology biopsy report

235

1.32

0.75

1.5

1.4

—

(3045414) Leukocytes [Presence] in Urine

161

1437

1.12

0.74

1.9

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.84

0.73

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

417

3899

1.08

0.73

3.7

4.5

9.28

22.75

ug/l

2.25

351

3248

(3011985) Renin [Units/volume] in Plasma

424

1.23

0.72

1.3

1.5

56.95

51.28

mu/l

0.11

376

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.79

0.72

2.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.55

0.71

1.2

25.38

35.91

—

(40768793) Breast Pathology biopsy report

571

1.19

0.71

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.75

0.71

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

169

1.36

0.69

2.1

3.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.85

0.68

3.0

4.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

170

1.35

0.67

1.6

1.7

1.44

3.40

u/field

0.90

124

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

283

0.74

0.66

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.78

0.66

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.51

0.65

2.8

3.5

8.98

8.12

mg/l

—

(3000285) Sodium [Moles/volume] in Blood

1.59

0.65

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

874

8402

1.05

0.63

3.8

3.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

578

0.83

0.63

1.9

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

174

1580

1.10

0.62

1.2

108.17

126.84

iu/ml

0.33

528

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.63

0.62

1.1

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.61

1.2

1.5

43.80

47.07

umol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

716

0.85

0.61

1.6

1.4

29.70

28.72

iu/l

0.07

601

(3043238) Trisomy 21 risk [Likelihood] in Fetus

137

0.66

0.60

1.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

536

1.18

0.60

5.1

4.9

349.61

357.75

umol/l

0.20

458

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.54

0.59

1.5

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.53

0.58

1.2

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

132

1.36

0.56

1.1

1.3

193.89

172.20

mmol/24h

0.36

132

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

115

1.39

0.56

3.1

2.4

142.62

139.92

nmol/l

0.04

101

(3020650) Glucose [Presence] in Urine

0.58

0.56

1.2

1.4

—

(4212803) Bone marrow aspirate examination

1.62

0.55

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

159

0.69

0.54

1.0

1.5

1.39

1.52

g/l

1.43

159

(1761482) Bacteria [#/volume] in Urine by Culture

919

0.88

0.54

4.0

3.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

392

4133

0.94

0.53

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

134

0.67

0.51

1.4

—

(3005033) Fetal Nuchal fold Thickness US

134

0.67

0.51

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

136

0.66

0.51

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

202

0.74

0.50

1.7

1.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

233

1.25

0.50

4.4

3.9

130.48

173.64

nmol/l

0.45

228

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

552

0.85

0.50

1.4

1.3

—

(40765096) Chromosome analysis panel by Banding

118

1.36

0.50

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

162

1.30

0.49

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

261

1.23

0.49

1.6

—

(3023410) Appearance of Cerebral spinal fluid

322

0.81

0.48

1.7

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

143

0.70

0.47

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

719

1.13

0.47

1.2

1.1

9.73

6.38

u/ml

0.35

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

466

1.16

0.46

1.3

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

887

8597

1.04

0.46

1.5

1.6

1.46

1.37

mmol/l

1.91

744

7160

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

696

0.87

0.46

1.5

1.6

146.29

919.71

e6/l

2.03

555

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

696

0.87

0.46

1.4

1.5

97.79

23.50

e6/l

0.38

532

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

120

1.33

0.45

1.8

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

662

0.87

0.44

1.3

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.45

0.44

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.61

0.43

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

338

0.83

0.42

1.1

—

2.22

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

8.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.09

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.20

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.0

—

(3003338) MCHC [Mass/volume]

2703

27279

0.97

0.39

35.8

18.1

329.72

333.10

g/l

60.91

2681

27033

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.43

0.39

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(40768804) Tissue Pathology biopsy report

1317

13422

0.97

0.39

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.34

0.38

1.1

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.30

0.37

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

161

1.24

0.36

1.5

1.2

151.79

138.88

nmol/l

0.39

161

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.36

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.36

0.36

1.0

2.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

198

1.21

0.36

2.2

2.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.33

0.35

1.3

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

134

0.74

0.35

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

172

1.22

0.34

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.33

0.33

1.2

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.32

0.33

1.2

1.4

57.58

373.76

nmol/24h

1.46

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

458

4418

1.04

0.33

4.6

4.4

31.00

31.65

0.68

347

2832

(3008401) Mugwort IgE Ab [Units/volume] in Serum

371

0.86

0.33

1.1

0.27

1.17

u/ml

1.92

158

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

284

1.16

0.32

1.8

2.0

2.18

2.15

u/field

0.01

100

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.28

0.32

2.7

3.5

39.43

40.92

umol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

172

1820

0.94

0.31

1.7

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

208

0.82

0.31

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.32

0.30

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

112

1042

1.08

0.30

1.6

—

(3005570) Glucose [Moles/volume] in Urine

302

0.86

0.28

1.5

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

251

1.16

0.28

1.2

1.6

0.17

0.26

nmol/l

0.99

191

(3032057) Clostridioides difficile [Presence] in Stool

1.32

0.28

1.6

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

198

1885

1.05

0.27

1.2

1.3

56.66

59.69

au/ml

—

119

(3020961) Endomysium IgA Ab [Titer] in Serum

130

1223

1.06

0.27

1.2

1.1

80.00

175.63

titre

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

749

0.92

0.26

5.7

3.3

28.28

27.40

mg/l

0.07

450

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

104

1.25

0.26

1.4

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.26

0.26

1.3

121.17

111.63

0.85

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.28

0.26

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.23

0.25

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.28

0.24

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

136

0.81

0.23

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

0.84

0.23

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.31

0.23

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.25

0.22

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

451

0.91

0.22

1.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

430

0.91

0.22

1.2

1.1

0.35

1.90

u/ml

4.34

219

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.19

0.21

3.6

2.9

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.21

0.0

2.0

—

0.08

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

1.05

—

(1617658) Protocol used for examination of sentinel lymph nodes

209

0.86

0.21

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

708

0.93

0.21

1.9

2.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

293

0.89

0.21

1.5

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.13

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.20

0.0

1.4

—

(40758358) Immune stain study

0.00

0.20

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.22

0.20

1.0

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

144

0.83

0.20

1.5

—

(3008295) Osmolality of Serum or Plasma

355

1.10

0.19

1.3

277.61

279.62

mosm/kgh2o

0.19

271

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

184

1.14

0.18

6.0

6.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

143

0.84

0.18

1.0

1.1

121.50

363.62

ng/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.21

0.17

1.1

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

382

0.91

0.17

1.1

4.32

5.07

u/ml

0.13

185

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

141

0.85

0.16

2.1

1.5

26.85

28.07

umol/l

0.24

135

(3010726) Horse dander IgE Ab [Units/volume] in Serum

339

0.91

0.16

1.2

1.1

0.98

1.55

u/ml

0.29

168

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

264

1.10

0.15

1.2

1.3

2.31

2.06

mmol/l

0.44

253

(3035933) Granulocytes/100 leukocytes in Blood

1.14

0.15

1.2

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.14

0.15

2.6

1.5

10.14

8.44

ug/l

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

439

1.07

0.14

4.1

3.4

6.15

20.19

nmol/l

0.57

431

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.79

0.14

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

150

1.13

0.14

4.5

3.8

—

(3008898) HLA-B27 [Presence]

838

0.95

0.14

1.1

—

(3048879) Bone marrow aspiration report

112

1.16

0.14

1.4

1.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

398

0.93

0.14

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

354

1.07

0.13

1.2

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

169

0.89

0.13

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.18

0.12

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

213

2078

1.03

0.12

2.3

2.4

9.83

24.32

au/ml

—

147

(3014133) Dog dander IgE Ab [Units/volume] in Serum

292

0.92

0.12

1.2

1.0

5.52

2.57

u/ml

0.43

135

(3011288) Drugs identified in Urine by Screen method

496

0.95

0.11

3.0

3.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

124

1.13

0.11

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

198

0.91

0.11

1.5

1.7

0.95

0.96

g/l

0.11

198

(3023430) Cat dander IgE Ab [Units/volume] in Serum

270

0.92

0.11

1.1

1.0

0.88

3.44

u/ml

—

109

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

131

1345

0.97

0.10

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

251

1.08

0.10

4.9

5.2

24.09

46.64

u/ml

1.15

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.14

0.10

2.2

1.9

19.80

16.90

umol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

292

2962

0.98

0.09

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.83

0.08

1.6

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.78

0.08

10.4

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.78

0.08

5.2

3.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.77

0.08

1.4

1.7

—

41.58

—

(3015183) Erythrocyte sedimentation rate

133

0.90

0.08

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

398

0.95

0.07

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

245

0.94

0.07

1.1

1.0

0.70

0.48

u/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

599

1.03

0.07

2.0

2.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.83

0.07

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

147

1.09

0.07

1.0

1.1

4.86

11.46

iu/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

147

1.09

0.07

1.0

—

(44813793) Dust mix specific IgE antibody measurement

162

0.92

0.06

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

162

0.92

0.06

1.1

0.92

1.17

u/l

—

(3028300) Cannabinoids [Presence] in Urine

764

0.98

0.04

2.2

2.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

190

1.05

0.03

8.6

14.6

936.90

823.60

nmol/l

0.40

178

(3027008) Opiates [Presence] in Urine

762

0.98

0.03

2.1

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

163

1641

0.99

0.02

1.6

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

830

1.01

0.01

2.8

2.6

—

(3027944) Amphetamines [Presence] in Urine

748

0.99

0.01

2.2

2.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

163

1.04

0.01

1.7

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

193

1.04

0.01

1.1

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

186

0.97

0.01

10.1

6.0

47.88

58.14

u/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.00

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.06

0.00

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

174

1.03

0.00

1.1

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

184

1.03

0.00

1.2

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

173

0.98

0.00

1.1

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

116

1.03

0.00

1.3

1.2

37.03

39.23

g/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

133

0.98

0.00

1.1

—

(3002256) Pathology report gross observation

458

4570

1.00

0.00

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

757

1.00

0.00

2.1

2.5

—

(3016879) Cocaine [Presence] in Urine

715

1.01

0.00

2.2

2.6

—

(4146454) Self-monitoring of blood glucose

396

1.01

0.00

2.4

2.7

—

(3022621) pH of Urine by Test strip

214

2142

1.00

0.00

3.1

3.0

—

(3025577) Chromium [Mass/volume] in Blood

235

0.98

0.00

2.0

1.36

1.90

ug/l

1.20

197

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

197

1.01

0.00

21.0

19.8

1593.15

1411.02

nmol/l

0.50

189

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1733.33

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.92

-0.00

1.3

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1326.44

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.88

-0.00

1.2

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.88

-0.00

1.4

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.93

-0.00

1.1

4.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.02

-0.00

1.0

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

3.4

—

4.40

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.2

—

0.22

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.94

-0.00

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: I9_NONISCHCARDMYOP_STRICT – Nonischemic cardiomyopathy

GWS hits: 7

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Nonischemic cardiomyopathy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Nonischemic cardiomyopathy (I9_NONISCHCARDMYOP_STRICT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints